Leerink Partners Downgrades Insulet to Market Perform, Lowers Price Target to $145
Benzinga Newsdesk 2 months ago
NewsDowngradesAnalyst RatingsPrice Target
Leerink Partners analyst Mike Kratky downgrades Insulet (NASDAQ:PODD) from Outperform to Market Perform and lowers the price target from $247 to $145.
Leerink Partners analyst Mike Kratky downgrades Insulet (NASDAQ:PODD) from Outperform to Market Perform and lowers the price target from $247 to $145.